Auransa is a startup based in the United States, 1 tracked investor.
Based in the United States, Auransa is a startup. Brouky records 1 investor associated with the company.
Auransa is a clinical stage, AI-native biopharma with a proprietary AI platform that harnesses available human disease data to discover novel therapeutics and raise the standard of care for cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.